For COVID testing, make an appointment at an Urgent Care or QuickCare location or visit hhs.gov.
If you have a medical emergency, visit one of our Emergency Departments.
404-605-6517 (main) 888-340-4493 (referrals)

Clinical Research

Advancing Heart Valve Research

At the Marcus Heart Valve Center, we actively engage in heart valve research. This allows us to offer customized diagnostic and therapeutic options for patients that may otherwise not be accessible.

Our leading-edge cardiac research program is focused on evaluating new treatments and technologies, particularly percutaneous (non-surgical/minimally invasive) treatment options for all heart valves. 

 

Currently Enrolling Research Trials

 

Aortic


ACURATE-IDE
Transcatheter Replacement of Stenotic Aortic Valve through Implantation of ACURATE in Subjects Indicated for TAVR.
ALIGN-AR
A Feasibility Study to Assess Safety and Effectiveness of the Transfemoral JenaValve Pericardial TAVR System in the Treatment of Patients with Symptomatic Severe Aortic Regurgitation.
COMPLETE TAVR
A Randomized, Comparative Effectiveness Study of Staged Complete Revascularization with Percutaneous Coronary Intervention to Treat Coronary Artery Disease vs. Medical Management Alone in Patients With Symptomatic Aortic Valve Stenosis Undergoing Elective Transfemoral Transcatheter Aortic Valve Replacement.
ProACT-Xa
A prospective, randomized, active (warfarin) controlled, parallel-arm clinical trial to determine if patients with an On-X aortic valve can be maintained safely and effectively on the factor Xa inhibitor apixaban.
SMART
Small Annuli Randomized to Evolut or SAPIEN Trial.

 


Mitral


APOLLO
Transcatheter Mitral Valve Replacement with the Medtronic Intrepid™ TMVR System in patients with severe symptomatic mitral regurgitation – APOLLO Trial.
Cephea Early Feasibility Study
To evaluate the preliminary safety and effectiveness of the Cephea Mitral Valve System for the treatment of symptomatic patients with mitral regurgitation > Grade III in whom transcatheter therapy is deemed more appropriate than open heart surgery.
CLASP II
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial (CLASP IID/IIF): A prospective, multicenter, randomized, controlled pivotal trial to evaluate the safety and effectiveness of transcatheter mitral valve repair with the Edwards PASCA.
Half Moon
Evaluation of the Safety and Performance of the Half Moon Transcatheter Mitral Valve Repair (TMVr) System in High Risk Patients with Severe Symptomatic Mitral Regurgitation.
HighLife EFS
An Early Feasibility Study of the HighLife 28mm Trans-Septal Transcatheter Mitral Valve Replacement System.
Intrepid TMVR EFS
Evaluation of the Safety and Performance of The Medtronic Intrepid™ Transcatheter Mitral Valve Replacement System with Transfemoral Transseptal access in Patients with Severe, Symptomatic Mitral Regurgitation.
REPAIR-MR
Percutaneous MitraClip™ Device or Surgical Mitral Valve Repair in Patients with Primary Mitral Regurgitation who are Candidates for Surgery.
RESTORE
A prospective, multi-center trial to evaluate the safety and effectiveness of beating heart mitral valve repair with the HARPOON™ System.
SUMMIT
Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation.

 

Tricuspid


Triluminate
Clinical Trial to Evaluate Cardiovascular Outcomes in Patients Treated with the Tricuspid Valve Repair System Pivotal (TRILUMINATE Pivotal).
TRISCEND EFS
Edwards EVOQUE Tricuspid Valve Replacement System: Investigation of Safety and Clinical Efficacy using a Novel Device.
Trisol EFS
Early Feasibility Study of the Trisol System.

 

For full details visit the Clinical Trials Database.

Piedmont App

Download the Piedmont Now app

  • Directions
  • Indoor Hospital Navigation
  • Find & Save Physicians
  • Online Scheduling

Download the app today!

Get the Piedmont Now on Google Play Get the Piedmont Now on iTunes App Store